Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Keefe, Bruyette & Woods Maintains Market Perform on CME Gr, Maintains $226 Price Target

Author: Benzinga Newsdesk | July 03, 2024 11:33am
Keefe, Bruyette & Woods analyst Kyle Voigt maintains CME Gr (NASDAQ:CME) with a Market Perform and maintains $226 price target.

Posted In: CME